Stock Market & Financial Investment News

News Breaks November 11, 2012 12:44 EDT RHHBY Genentech announced that ADACTA study results will be presented oN November 11 Genentech, a member of the Roche Group announced that results from the ADACTA study will be presented on November 11 during an oral presentation at the 2012 American College of Rheumatology, ACR, Annual Scientific Meeting in Washington, D.C. Results from the study showed ACTEMRA (tocilizumab) improved signs and symptoms (DAS28 score reduction) of rheumatoid arthritis (RA) significantly more than adalimumab when used alone as a single-agent therapy (without other disease-modifying antirheumatic drugs, DMARDs, including methotrexate). RA patients are often treated with a combination of medicines that typically include a biologic medicine, such as ACTEMRA or adalimumab, plus methotrexate. However, about one in three patients on a biologic treatment such as ACTEMRA or adalimumab receive it as a single-agent therapy, largely due to intolerance to methotrexate. News For RHHBY From The Last 14 Days Check below for free stories on RHHBY the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 15:19 EDT RHHBY FDA announces approval of Roche diabetes test Subscribe for More Information May 22, 2013 10:33 EDT RHHBY Bristol-Myers jumps after Citi ups rating on cancer potential Subscribe for More Information 10:00 EDT RHHBY On The Fly: Analyst Upgrade Summary Subscribe for More Information 06:02 EDT RHHBY Roche upgraded to Buy from Neutral at Citigroup Subscribe for More Information May 21, 2013 20:03 EDT RHHBY Roche, Sigma-Aldrich teamed for Life bid, Reuters says Subscribe for More Information May 20, 2013 17:26 EDT RHHBY Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement' Subscribe for More Information 17:20 EDT RHHBY Regeneron,, Bayer, Genentech resolve certain patent disputes Subscribe for More Information May 15, 2013 15:59 EDT RHHBY Roche exploring sale of blood glucose meters unit, Reuters says Subscribe for More Information 12:13 EDT RHHBY Roche management to meet with Jefferies Meeting to be held in London on May 17 hosted by Jefferies. 11:38 EDT RHHBY Roche says FDA approves Tarceva tablets for specific lung cancer situation Subscribe for More Information May 14, 2013 16:55 EDT RHHBY FDA approves Roche's cobas EGFR mutation test with Tarceva Subscribe for More Information May 13, 2013 08:55 EDT RHHBY Biosimiliar drug bill to be taken up in Senate, LA Times reports Subscribe for More Information 07:30 EDT RHHBY TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. May 10, 2013 15:59 EDT RHHBY Roche spokesman reiterates that Illumina is "off the table," Bloomberg reports Subscribe for More Information 11:48 EDT RHHBY Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.